Skip to Content
Biotechnology

The fight over who owns CRISPR is back, and it’s a rematch

USPTO signage
USPTO signageReubenGBrewer, Wikimedia

The dispute over valuable patents to the gene-editing tool CRISPR is back on, and the belligerents are once again the Broad Institute of Cambridge, Massachusetts, and the University of California, reports STAT News.

The dispute: It’s all about money, power, and scientific credit. In short, it’s about who really invented CRISPR gene editing, a simple way to modify the DNA inside cells that’s swept the world and could be the basis for a new generation of gene-therapy treatments.

The sides: In one corner, UC Berkeley, where biochemist Jennifer Doudna was part of a team that in 2012 described a CRISPR editor able to zap DNA in a test tube. In the other, the Broad Institute of MIT /Harvard, a genomics juggernaut whose star scientist, Feng Zhang, was among the first to use CRISPR to edit human DNA.

The news: This week, the US Patent Office opened an “interference” proceeding. That means it’s going to take a bundle of patents and patent applications it thinks cover the same inventions and, following a court-like legal proceeding, potentially shift rights around among the feuding parties.

It’s not the first interference involving CRISPR patents. In a previous round, the Broad Institute prevailed when the patent office ruled that making CRISPR work inside human cells—not only in a test tube—was a distinct and separate invention. That meant Broad’s key patents stayed in place. For the time being.

Now that it's clear that CRISPR in human cells is its own thing, a new challenge begins. The patent office needs to sort out a thicket of competing and conflicting claims and figure out who the invention should belong to.  

According to case documents, it’s up to the Broad Institute to avoid further trouble (and lawyer fees) by initiating settlement agreements with Berkeley. So far the parties haven't been able to reach a truce.

Deep Dive

Biotechnology

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

How do strong muscles keep your brain healthy?

There’s a robust molecular language being spoken between your muscles and your brain.

The quest to show that biological sex matters in the immune system

A handful of immunologists are pushing the field to take attributes such as sex chromosomes, sex hormones, and reproductive tissues into account.

This company is about to grow new organs in a person for the first time

A volunteer with severe liver disease will soon undergo a procedure that could lead them to grow a second liver.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.